Neuromyelitis Optica Spectrum Disorder
📧 Sign up to get email alerts when something new happens for Neuromyelitis Optica Spectrum Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: A Study of MIL62 in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD) [Phase 3]
Phase 3 clinical trial of MIL62 for neuromyelitis optica spectrum disorder is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder [Phase 2]
Clinical trial update indicating a Phase 2 study of eculizumab for acute attacks in neuromyelitis optica spectrum disorder is currently recr…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Efficacy and Safety of Monoclonal Antibody in Acute Phase of Neuromyelitis Optica Spectrum Disorder
A clinical trial update reports on the efficacy and safety of a monoclonal antibody in the acute phase of Neuromyelitis Optica Spectrum Diso…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD
Clinical trial update on monoclonal antibody therapies for AQP4-positive neuromyelitis optica spectrum disorder, with recruitment ongoing at…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Inectolizumab With Steroid Optimization in Newly Treated NMOSD [NA]
Clinical trial update indicates Inectolizumab with steroid optimization is being studied for newly treated neuromyelitis optica spectrum dis…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD) [EARLY_Phase 1]
An early-phase (EARLY_PHASE1) clinical study of B001 Injection in Neuromyelitis optica spectrum disorder is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Study of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum Disorder
A study is evaluating the clinical and radiological effects of ravulizumab in people with neuromyelitis optica spectrum disorder. Recruitmen…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases [NA]
A clinical trial update indicates a study evaluating transcranial alternating current stimulation for cognitive impairment in idiopathic inf…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Clinical Study to Evaluate the Effects of the Complement C5 Inhibitor Ravulizumab on Serum Neurofilament Light Chain (sNfL) and Glial Fibrillary Acidic Protein (sGFAP) Levels in Patients With Aquaporin-4-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD)
A clinical study is evaluating the effects of ravulizumab, a complement C5 inhibitor, on serum biomarkers sNfL and sGFAP in patients with Aq…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Effects of Transcranial Electrical Stimulation on Cognitive Impairment in CNS Inflammatory Demyelinating Diseases [NA]
A clinical trial is evaluating whether transcranial electrical stimulation can improve cognitive impairment in CNS inflammatory demyelinatin…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating BAFF-R CAR-T cell therapy for refractory neuroimmune diseases is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases [Phase 1]
This Phase 1 study evaluates LCAR-AIO CAR-T cells for relapsed/refractory neurological autoimmune diseases, recruiting at a major Chinese me…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Biorepository and Registry for Plasma Exchange Patients
A clinical trial update announcing a biorepository and registry for patients undergoing plasma exchange, with recruiting status and listed i…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
Clinical trial registry update for the PRISMA pregnancy registry, collecting data on infants and maternal serum/milk analysis to assess expo…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD [NA]
This clinical trial evaluates the impact of a Structured Wellness Behavioral Intervention on quality of life for people with Neuromyelitis O…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD [NA]
Clinical trial update on a digital tool for unsupervised self-assessment in neuromyelitis optica spectrum disorder; the study is currently r…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Meningococcal Vaccination in Patients on Complement Inhibitors
This clinical trial update concerns meningococcal vaccination in patients treated with complement inhibitors. It includes patients with gene…
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD) [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating B001 Injection for Neuromyelitis Optica Spectrum Disorders is currently recruiting. The sponsor listed…
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: Comparative Study on AQP4 Antibody Detection Methods
This clinical trial update describes a comparative study of AQP4 antibody detection methods in NMOSD, sponsored by the First Affiliated Hosp…
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)
Clinical and imaging cohort study in China (CLUE) recruiting to collect data on neuroinflammatory diseases, including Neuromyelitis optica s…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
Swiss-Ped-IBrainD is a pediatric brain inflammation registry sponsored by the University of Bern and is currently recruiting, enrolling chil…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD) [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of JYP0061 in patients with Neuromyelitis Optica Spectrum Disorder (NMOSD) is cu…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Biomarkers in Autoimmune Disease of Nervous System
A Tongji Hospital clinical trial is recruiting to study biomarkers in autoimmune diseases of the nervous system, including Neuromyelitis Opt…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System [EARLY_Phase 1]
An early-phase clinical trial is investigating CT103A cell therapy for relapsed/refractory antibody-associated inflammatory diseases of the …
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the efficacy and safety of baricitinib in neuromyelitis optica spectrum disorder, currently recruiting…